Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow-to-Debt Ratio
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of CN¥21.03 Million could theoretically repay 0% of its total liabilities (CN¥82.76 Million) in one year. See 688091 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Shanghai Yizhong Pharmaceutical Co Ltd across 8 annual periods. Also explore net asset growth rate of Shanghai Yizhong Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Year-by-year debt coverage analysis for Shanghai Yizhong Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shanghai Yizhong Pharmaceutical Co Ltd (688091) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥39.44 Million | CN¥42.97 Million | ▲ +15.1% |
| 2023 | 0.80x | CN¥86.55 Million | CN¥108.52 Million | ▼ -74.5% |
| 2022 | 3.13x | CN¥110.78 Million | CN¥35.42 Million | ▲ +260.4% |
| 2021 | -1.95x | CN¥-48.78 Million | CN¥25.02 Million | ▼ -47.6% |
| 2020 | -1.32x | CN¥-20.21 Million | CN¥15.30 Million | ▲ +32.3% |
| 2019 | -1.95x | CN¥-23.91 Million | CN¥12.26 Million | ▼ -212.9% |
| 2018 | -0.62x | CN¥-10.68 Million | CN¥17.15 Million | ▲ +12.5% |
| 2017 | -0.71x | CN¥-11.51 Million | CN¥16.17 Million | — |